Description

Tojeo SoloStar (insulin glargine) solution for injections 300 IU/ml. 1.5 ml. №3 cart. syringe

Ingredients:

Tojeo SoloStar contains insulin glargine as the active ingredient. Other ingredients include glycerol, metacresol, zinc oxide, hydrochloric acid, and sodium hydroxide.

Dosage:

Tojeo SoloStar is administered subcutaneously once daily at the same time each day. The dosage may vary depending on the individual’s needs and should be determined by a healthcare provider.

Indications:

Tojeo SoloStar is indicated for the treatment of diabetes mellitus in adults. It helps control blood sugar levels and is essential for managing diabetes effectively.

Contraindications:

Tojeo SoloStar is contraindicated in patients with hypersensitivity to insulin glargine or any other components of the solution. It should not be used during episodes of hypoglycemia.

Directions:

Before each use, inspect the solution visually for any particles or discoloration. Administer the injection subcutaneously into the thigh, abdomen, or upper arm. Rotate injection sites to prevent lipodystrophy.

Scientific Evidence:

Studies have shown that Tojeo SoloStar provides effective glycemic control in patients with diabetes. Research published in the Journal of Diabetes Science and Technology demonstrated the long-acting and stable glucose-lowering effects of insulin glargine.

Additional Information:

It is important to monitor blood sugar levels regularly while using Tojeo SoloStar to adjust the dosage as needed. Consult a healthcare professional for proper guidance on insulin administration and diabetes management.

Tojeo SoloStar works by mimicking the natural insulin produced by the body, helping to regulate glucose levels in the blood. It has a prolonged duration of action, providing a steady release of insulin over 24 hours.

Compared to other insulin formulations, Tojeo SoloStar offers the advantage of once-daily dosing, reducing the frequency of injections for patients with diabetes. Clinical trials have shown its efficacy in improving glycemic control and reducing the risk of hypoglycemia.